While some are still in the clinical trial stage, the following vaccines are currently available: Pediarix is a combination vaccine that combines the immunizations for Diphtheria, Tetanus and acellular Pertussis (DTaP), Hepatitis B and inactivated Polio (IPV), which used to require three separate shots. Pediarix is given to children as a three dose series at 2, 4, and 6 months. So instead of 9 shots for the series to get protection against Diptheria, Tetanus, Pertussis (Whooping Cough), Hepatitis B and Polio, you can now get the same protection for your kids in just 3 shots.
In all clinical trials, the typical process starts with a screening period. The screening period starts with the signing of the informed consent. During the screening period, inclusion/exclusion criteria for the study participation will be checked / tested. Subjects who meet all inclusion criteria and do not meet any exclusion criterion will be eligible to be randomized (in randomized trial) or to be dosed (in non-randomized trial).
A clinical trial is usually implemented by physicians at a hospital, clinic, or physician's office. The CRA is required to oversee the initiation, progress, and conduct of the clinical trial to ensure the scientific integrity of the data collected, and the protection of the rights, safety, and well-being of human study subjects. The CRAâs responsibilities include but are not limited to the following: 1  Monitoring that the physician adheres to Good Clinical Practices and the study protocol. 2  Performing study drug accountability; 3  Verifying the documentation of the informed consent process for each study subject;